nach oben

Reactions Weekly

Erschienen in:

01.10.2016 | Case report

Ferric carboxymaltose

Dyspnoea and urticaria: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective review, 2 patients [ages and sexes not stated] were described, out of which one patient developed urticaria following administration of test dose of ferric carboxymaltose, and another patient developed urticaria and dyspnoea during administration of IV ferric carboxymaltose infusion [dosages, durations of treatments to reactions onsets and outcomes not stated]. Both patients had a history of hypersensitivity reactions to IV iron [specific drugs not stated]. …

Morales Mateluna CA, et al. Value of re-exposure in patients with previous hypersensitivity reactions to intravenous iron. Allergy 71 (Suppl. 102): 265-266 abstr. 572, Aug 2016. Available from: URL: http://doi.org/10.1111/all.12972 [abstract] - Switzerland

Titel: Ferric carboxymaltose
Dyspnoea and urticaria: 2 case reports
Publikationsdatum: 01.10.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-21662-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Benznidazole

Amitriptyline

Metronidazole

Cotrimoxazole

Sulfadiazine

Metronidazole